[go: up one dir, main page]

CN116716251A - A single cell processing method for vitreous samples and its application - Google Patents

A single cell processing method for vitreous samples and its application Download PDF

Info

Publication number
CN116716251A
CN116716251A CN202310739258.2A CN202310739258A CN116716251A CN 116716251 A CN116716251 A CN 116716251A CN 202310739258 A CN202310739258 A CN 202310739258A CN 116716251 A CN116716251 A CN 116716251A
Authority
CN
China
Prior art keywords
pbs
vitreous
cell processing
digestion
processing method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202310739258.2A
Other languages
Chinese (zh)
Inventor
李雅倩
张美芬
张潇
钱宇婧
石正明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Peking Union Medical College Hospital Chinese Academy of Medical Sciences
Original Assignee
Peking Union Medical College Hospital Chinese Academy of Medical Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peking Union Medical College Hospital Chinese Academy of Medical Sciences filed Critical Peking Union Medical College Hospital Chinese Academy of Medical Sciences
Priority to CN202310739258.2A priority Critical patent/CN116716251A/en
Publication of CN116716251A publication Critical patent/CN116716251A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0693Tumour cells; Cancer cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N15/14Optical investigation techniques, e.g. flow cytometry
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00Methods for the dissociation of cells, e.g. specific use of enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention provides a single-cell processing method of a vitreous sample and application thereof. The single-cell processing method of the vitreous body sample comprises the following steps of S1, digestive juice composition of the vitreous body sample: comprises one or more of collagenase, pancreatin and dispase, wherein the concentration is 0.1% -2%, and 0.5% -1.5% FBS is dissolved in PBS; s2, immediately placing the patient vitreous body sample on ice for transportation, transferring the tissue into a 50mL centrifuge tube, and adding 10ml of digestive juice in the S1; s3, placing the centrifuge tube in a shaking table for digestion; s4, after digestion, adding 0.5-1.5 ml of FBS and 2.5-10 ml of PBS to terminate; s5, then centrifuging at 800g for 5min, and carefully discarding the supernatant; s6, diluting the split red with 5-time volume PBS for 1-5 min, and centrifuging. The single-cell processing method and the application of the vitreous body sample provided by the invention have the advantages of capability of obtaining active cells with high activity and high purity, simplicity and rapidness in operation, no need of expensive instruments and reagents and high cell activity rate.

Description

一种玻璃体样本的单细胞处理方法及其应用A single cell processing method for vitreous samples and its application

技术领域Technical field

本发明涉及单细胞处理技术领域,尤其涉及一种玻璃体样本的单细胞处理方法及其应用。The present invention relates to the technical field of single cell processing, and in particular to a single cell processing method for vitreous samples and its application.

背景技术Background technique

原发性玻璃体视网膜淋巴瘤(primaryvitreoretinallymphoma,PVRL)是原发性中枢神经系统淋巴瘤(primarycentralnervous systemlymphoma,PCNSL)的一个亚型,是一种罕见的致命性眼部恶性肿瘤,97%患者病理类型是侵袭性B细胞淋巴瘤。PVRL常被误诊为葡萄膜炎,94.5%患眼表现为玻璃体白色点状混浊,60.3%患眼表现为视网膜下黄白色浸润灶。由于眼内标本取材、病理诊断困难,该病平均确诊时间13.4个月。Primary vitreoretinal lymphoma (PVRL) is a subtype of primary central nervous system lymphoma (primary central nervous system lymphoma (PCNSL)). It is a rare and fatal ocular malignant tumor. The pathological type of 97% of patients is Aggressive B-cell lymphoma. PVRL is often misdiagnosed as uveitis, with 94.5% of the affected eyes showing white punctate vitreous opacity, and 60.3% of the affected eyes showing yellow-white subretinal infiltrates. Due to the difficulty of intraocular specimen collection and pathological diagnosis, the average diagnosis time of this disease is 13.4 months.

PVRL诊断的金标准是病理诊断,然而PVRL是非实体瘤,大量淋巴瘤细胞漂浮于玻璃体腔及散在于视网膜下。为明确诊断,需要做玻璃体切除术,取出玻璃体原液约1.5ml。玻璃体是无色透明的胶状体,主要由水、透明质酸和胶原纤维构成,淋巴瘤细胞与玻璃体胶原纤维粘附在一起,很难游离成为单细胞,并且该瘤细胞极其脆弱,离体2小时即融解从而失去其原始细胞形态。因此,病理诊断阳性率比较低,取而代之的是不同的分子或者基因诊断。The gold standard for PVRL diagnosis is pathological diagnosis. However, PVRL is a non-solid tumor with a large number of lymphoma cells floating in the vitreous cavity and scattered under the retina. To confirm the diagnosis, vitrectomy is required, and about 1.5ml of vitreous fluid is removed. The vitreous body is a colorless and transparent colloid, mainly composed of water, hyaluronic acid and collagen fibers. Lymphoma cells adhere to the vitreous collagen fibers and are difficult to dissociate into single cells. Moreover, the tumor cells are extremely fragile and cannot be separated from the body. It thaws within 2 hours and loses its original cell shape. Therefore, the positive rate of pathological diagnosis is relatively low, and is replaced by different molecular or genetic diagnosis.

为了提高病理诊断阳性率及研究肿瘤细胞的生物学行为,亟需一种有效方法将淋巴瘤细胞从胶栋样玻璃体中分离出来,并且需要保证细胞的纯度、数量和活性,因此,有必要提供一种新的玻璃体样本的单细胞处理方法及其应用解决上述技术问题。In order to improve the positive rate of pathological diagnosis and study the biological behavior of tumor cells, an effective method is urgently needed to separate lymphoma cells from the colloid vitreous, and the purity, quantity and activity of the cells need to be ensured. Therefore, it is necessary to provide A new single-cell processing method for vitreous samples and its application solve the above technical problems.

发明内容Contents of the invention

本发明解决的技术问题是提供一种可以得到高活性、高纯度的活性细胞,操作简单快速,且不需要昂贵的仪器设备和试剂,细胞活率高的玻璃体样本的单细胞处理方法及其应用。The technical problem solved by the present invention is to provide a single cell processing method and application for vitreous samples that can obtain high activity and high purity active cells, is simple and fast to operate, does not require expensive equipment and reagents, and has high cell viability. .

为解决上述技术问题,本发明提供的玻璃体样本的单细胞处理方法及其应用包括:S1、玻璃体样本的消化液组成为:包括胶原酶、胰酶和分散酶的一种或两种及以上组合,浓度为0.1%-2%,以及0.5%~1.5%FBS溶于PBS;S2、采集患者玻璃体样本后立即置于冰上运输,将组织转移50mL离心管内,并加入S1中10ml的消化液;S3、将离心管置于摇床消化;S4、消化后,加入0.5~1.5mlFBS和2.5~10ml PBS终止;S5、然后800gx5min离心,小心弃上清;S6、裂红1~5min后,用5倍体积PBS稀释后离心;S7、用0.02%~0.06%PBS-BSA或含0.5%~1.5%FBS的PBS清洗1次,离心500gx5min;S8、清洗后,用0.04%PBS-BSA重悬,台盼蓝染色并计数后。In order to solve the above technical problems, the single cell processing method of vitreous samples and its application provided by the present invention include: S1. The digestive juice of the vitreous sample is composed of: one or a combination of two or more types of collagenase, trypsin and dispase. , with a concentration of 0.1%-2%, and 0.5%-1.5% FBS dissolved in PBS; S2. Collect the patient's vitreous sample and immediately place it on ice for transportation, transfer the tissue into a 50mL centrifuge tube, and add 10ml of the digestive fluid in S1; S3. Place the centrifuge tube on a shaker for digestion; S4. After digestion, add 0.5-1.5ml FBS and 2.5-10ml PBS to terminate; S5. Then centrifuge at 800gx5min and carefully discard the supernatant; S6. After 1-5min of split red, use 5 Dilute with twice the volume of PBS and centrifuge; S7, wash once with 0.02% ~ 0.06% PBS-BSA or PBS containing 0.5% ~ 1.5% FBS, centrifuge at 500gx5min; S8, after washing, resuspend with 0.04% PBS-BSA, set aside After staining with pan blue and counting.

优选的,S3中摇床消化温度为37℃,转速为50-100rpm,消化时间10-60min。Preferably, the digestion temperature of the shaking table in S3 is 37°C, the rotation speed is 50-100 rpm, and the digestion time is 10-60 minutes.

优选的,S2中采集患者玻璃体样本的体积为1ml。Preferably, the volume of the patient's vitreous sample collected in S2 is 1 ml.

与相关技术相比较,本发明提供的玻璃体样本的单细胞处理方法及其应用具有如下有益效果:Compared with related technologies, the single cell processing method for vitreous samples provided by the present invention and its application have the following beneficial effects:

本发明提供一种玻璃体样本的单细胞处理方法及其应用,可以得到高活性、高纯度的活性细胞,操作简单快速,且不需要昂贵的仪器设备和试剂,细胞活率最高可达到84%,本发明分离消化方法高效、快速,已经成功从玻璃体中提取高活性和纯度的淋巴瘤细胞,用于单细胞测序研究,适于推广应用。The invention provides a single cell processing method for vitreous samples and its application, which can obtain high-activity, high-purity active cells. The operation is simple and fast, and does not require expensive equipment and reagents. The cell viability rate can reach up to 84%. The separation and digestion method of the present invention is efficient and fast, and has successfully extracted highly active and pure lymphoma cells from the vitreous body for single-cell sequencing research, and is suitable for popularization and application.

附图说明Description of the drawings

图1为本发明提供的玻璃体样本的单细胞处理方法及其应用得到的活性细胞图。Figure 1 is a diagram of active cells obtained by the single cell processing method of vitreous samples provided by the present invention and its application.

具体实施方式Detailed ways

下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings in the embodiments of the present invention. Obviously, the described embodiments are only some of the embodiments of the present invention, rather than all the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those of ordinary skill in the art without creative efforts fall within the scope of protection of the present invention.

请结合参阅图1,玻璃体样本的单细胞处理方法及其应用包括:S1、玻璃体样本的消化液组成为:包括胶原酶、胰酶和分散酶的一种或两种及以上组合,浓度为0.1%-2%,以及0.5%~1.5%FBS溶于PBS;S2、采集患者玻璃体样本后立即置于冰上运输,以玻璃体淋巴瘤样本为例,消化处理得到单细胞悬液,用于单细胞转录组测序的研究,将组织转移50mL离心管内,并加入S1中10ml的消化液;S3、将离心管置于摇床消化;S4、消化后,加入1mlFBS和5mlPBS终止;S5、然后800gx5min离心,小心弃上清;S6、裂红1~5min后,用5倍体积PBS稀释后离心;S7、用0.02%~0.06%PBS-BSA或含0.5%~1.5%FBS的PBS清洗1次,离心500gx5min;S8、清洗后,用100μL0.04%PBS-BSA重悬,台盼蓝染色并计数后,图中亮点为活性细胞。Please refer to Figure 1 in conjunction with the single cell processing method and application of vitreous samples including: S1. The composition of the digestive fluid of vitreous samples is: including one or two or more combinations of collagenase, trypsin and dispase, with a concentration of 0.1 %-2%, and 0.5% to 1.5% FBS dissolved in PBS; S2. Collect the patient's vitreous samples and immediately place them on ice for transportation. Taking vitreous lymphoma samples as an example, digest and process to obtain a single cell suspension for single cell For transcriptome sequencing research, transfer the tissue into a 50mL centrifuge tube and add 10ml of the digestion solution in S1; S3, place the centrifuge tube on a shaker for digestion; S4, after digestion, add 1mlFBS and 5mlPBS to terminate; S5, then centrifuge at 800gx5min. Carefully discard the supernatant; S6, after 1 to 5 minutes of splitting the red, dilute with 5 times the volume of PBS and centrifuge; S7, wash once with 0.02% to 0.06% PBS-BSA or PBS containing 0.5% to 1.5% FBS, and centrifuge at 500gx5min ; S8. After washing, resuspend with 100 μL 0.04% PBS-BSA. After trypan blue staining and counting, the bright spots in the picture are active cells.

S3中摇床消化温度为37℃,转速为50-100rpm,消化时间10-60min。The digestion temperature of the shaking table in S3 is 37°C, the rotation speed is 50-100 rpm, and the digestion time is 10-60 minutes.

S2中采集患者玻璃体样本的体积为1ml。The volume of the patient's vitreous sample collected in S2 was 1 ml.

玻璃体样本的单细胞处理方法在单细胞测序中或流式细胞术检测中等的应用。Single-cell processing of vitreous samples for applications such as single-cell sequencing or flow cytometry.

与相关技术相比较,本发明提供的玻璃体样本的单细胞处理方法及其应用具有如下有益效果:Compared with related technologies, the single cell processing method for vitreous samples provided by the present invention and its application have the following beneficial effects:

本发明提供一种玻璃体样本的单细胞处理方法及其应用,可以得到高活性、高纯度的活性细胞,操作简单快速,且不需要昂贵的仪器设备和试剂,细胞活率最高可达到84%,本发明分离消化方法高效、快速,已经成功从玻璃体中提取高活性和纯度的淋巴瘤细胞,用于单细胞测序研究,适于推广应用。The invention provides a single cell processing method for vitreous samples and its application, which can obtain high-activity, high-purity active cells. The operation is simple and fast, and does not require expensive equipment and reagents. The cell viability rate can reach up to 84%. The separation and digestion method of the present invention is efficient and fast, and has successfully extracted highly active and pure lymphoma cells from the vitreous body for single-cell sequencing research, and is suitable for popularization and application.

以上所述仅为本发明的实施例,并非因此限制本发明的专利范围,凡是利用本发明说明书及附图内容所作的等效结构或等效流程变换,或直接或间接运用在其它相关的技术领域,均同理包括在本发明的专利保护范围内。The above are only examples of the present invention, and do not limit the patent scope of the present invention. Any equivalent structure or equivalent process transformation made by using the description and drawings of the present invention, or directly or indirectly applied to other related technologies fields are equally included in the scope of patent protection of the present invention.

Claims (4)

1. A method for single cell processing of a vitreous sample, comprising the steps of:
s1, the digestive juice composition of the vitreous body sample is as follows: comprises one or more of collagenase, pancreatin and dispase, wherein the concentration is 0.1% -2%, and 0.5% -1.5% FBS is dissolved in PBS;
s2, immediately placing the patient vitreous body sample on ice for transportation, transferring the tissue into a 50mL centrifuge tube, and adding 10ml of digestive juice in the S1;
s3, placing the centrifuge tube in a shaking table for digestion;
s4, after digestion, adding 0.5-1.5 ml of FBS and 2.5-10 ml of PBS to terminate;
s5, centrifuging at 800g×5min, and carefully discarding the supernatant;
s6, diluting with PBS (phosphate buffer solution) with 5 times of volume and centrifuging after 1-5 minutes of red burst;
s7, washing with 0.02% -0.06% PBS-BSA or PBS containing 0.5% -1.5% FBS for 1 time, and centrifuging 500g x5min;
s8, after washing, 100 mu L of 0.04% PBS-BSA was resuspended, and trypan blue was stained and counted.
2. The method for single-cell processing of a vitreous sample according to claim 1, wherein the shaking table digestion temperature in S3 is 37 ℃, the rotation speed is 50-100rpm, and the digestion time is 10-60min.
3. The method for single-cell processing of a vitreous sample and its use according to claim 2, wherein the volume of the vitreous sample of the patient collected in S2 is 1ml.
4. Use of the method of any one of claims 1-3 in single cell sequencing or flow cytometry detection, among others.
CN202310739258.2A 2023-06-20 2023-06-20 A single cell processing method for vitreous samples and its application Pending CN116716251A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202310739258.2A CN116716251A (en) 2023-06-20 2023-06-20 A single cell processing method for vitreous samples and its application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202310739258.2A CN116716251A (en) 2023-06-20 2023-06-20 A single cell processing method for vitreous samples and its application

Publications (1)

Publication Number Publication Date
CN116716251A true CN116716251A (en) 2023-09-08

Family

ID=87871311

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202310739258.2A Pending CN116716251A (en) 2023-06-20 2023-06-20 A single cell processing method for vitreous samples and its application

Country Status (1)

Country Link
CN (1) CN116716251A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09107957A (en) * 1995-04-21 1997-04-28 Yoshitaka Obara Culture of crystalline lens and apparatus for culturing the lens
CN1738641A (en) * 2002-12-06 2006-02-22 思罗姆-X股份有限公司 pharmacological vitreolysis
CN101711737A (en) * 1999-03-02 2010-05-26 透明视网膜技术公司 Agents for intravitreal administration to treat or prevent disorders of the eye
CN111925988A (en) * 2020-08-29 2020-11-13 郑州大学 Method for preparing single cell suspension based on retina tissue/organoid-retina tissue
CN120137899A (en) * 2025-03-26 2025-06-13 北京市眼科研究所 A method for extracting cells by enzymatic hydrolysis of vitreous body

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09107957A (en) * 1995-04-21 1997-04-28 Yoshitaka Obara Culture of crystalline lens and apparatus for culturing the lens
CN101711737A (en) * 1999-03-02 2010-05-26 透明视网膜技术公司 Agents for intravitreal administration to treat or prevent disorders of the eye
CN1738641A (en) * 2002-12-06 2006-02-22 思罗姆-X股份有限公司 pharmacological vitreolysis
CN111925988A (en) * 2020-08-29 2020-11-13 郑州大学 Method for preparing single cell suspension based on retina tissue/organoid-retina tissue
CN120137899A (en) * 2025-03-26 2025-06-13 北京市眼科研究所 A method for extracting cells by enzymatic hydrolysis of vitreous body

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
张惠蓉: "《视网膜病临床和基础研究》", vol. 1995, 31 October 1995, 山西科学技术出版社, pages: 1 - 4 *
李根林等: "人眼玻璃体切除液体外组织细胞培养技术的建立", 中华眼科杂志, no. 12, 18 February 2009 (2009-02-18) *

Similar Documents

Publication Publication Date Title
US7311905B2 (en) Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
AU2008249204B2 (en) Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
Gorius et al. Fine structure and peroxidase activity of circulating micromegakaryoblasts and platelets in a case of acute myelofibrosis
KR20200028045A (en) Use of umbilical cord blood in the treatment of premature birth complications
CN111575236A (en) Preparation method of human liver cancer tissue and liver tissue active single cell suspension
CN116904394A (en) Preparation method and application of anti-inflammatory mesenchymal stem cell-derived exosomes
CN113980814B (en) Composition for rapidly lysing peripheral red blood cells and application thereof
CN111534476A (en) A method for dissociating and separating shellfish testis spermatogenic cells
CN116716251A (en) A single cell processing method for vitreous samples and its application
CN111759864B (en) Application of amniotic fluid stem cells in preparation of medicine for treating lupus nephritis
CN107227296A (en) A kind of method of myelomonocyte separation, identification and induction differentiation
CN116875536A (en) A mixed enzyme solution for ovarian tissue dissociation and its kit
CN116286605A (en) Reagent, kit and method for preparing fibrotic liver single cell suspension
CN118298920A (en) Cell quality attribute detection method, detection device and application
CN114276980A (en) A method for culturing pancreatic islet cells suitable for clinical application
CN118883400A (en) Reagent composition for detecting GZMK+CD8+T cells and its application
CN117586956A (en) Dissociation solution combination, kit and method for preparing single cell suspension of human breast cancer tissue
CN114574438A (en) Separation method of human decidua MDSCs
CN114324860A (en) A method for assessing the correlation between plasmablasts and pancreatic islet immune damage
CN118703435A (en) Method for preparing tumor-infiltrating lymphocytes derived from tumor tissue and metastatic lymph nodes
CN116478922A (en) A kind of preparation method of umbilical cord blood stem cell and the prepared stem cell bank
CN118086200A (en) Separation method of bone marrow mononuclear cells of cynomolgus monkey
WO2025020214A1 (en) Method for culturing novel artificial blood of nucleated red blood cells
NZ579705A (en) Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
Worti et al. Association of sickle cell trait in blood donors with baseline hematological and biochemical parameters of whole blood

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination